Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00648986 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT00648986 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 20 participants.
The verdict
NCT00648986, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether topical tazarotene (Tazorac), a receptor-selective synthetic retinoid that normalizes epidermal differentiation, ameliorates signs and symptoms of brittle nails.
Interventions
- DRUG Tazorac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00648986
The ClinicalTrials.gov registry entry for NCT00648986 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tazorac is the first listed.
NCT00648986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00648986 about?
NCT00648986 is a clinical study titled "Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails". The purpose of this study is to determine whether topical tazarotene (Tazorac), a receptor-selective synthetic retinoid that normalizes epidermal differentiation, ameliorates signs and symptoms of brittle nails.
What is the current status of trial NCT00648986?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-08. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00648986?
The interventions under investigation include: Tazorac (DRUG).
Who is sponsoring clinical trial NCT00648986?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.